Area of research
Immunology and Allergy · Physiology
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Occupational exposure and asthma, and Food Allergy and Anaphylaxis Research.
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A <scp>MASK</scp> ‐air and <scp>EAACI</scp> Methodological Committee Report
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
<scp>EAACI</scp>Molecular Allergology User's Guide 2.0
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
Improvement of daily allergy control by sublingual immunotherapy: A <scp>MASK</scp>‐air® study
Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA<sup>2</sup>LEN consensus
Molecular allergology and its impact in specific allergy diagnosis and therapy
Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma